Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.

Launched by AUSTRALIAN CATHOLIC UNIVERSITY · Mar 14, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how different types of diet support can help people with type 2 diabetes manage their blood sugar levels. Specifically, the researchers want to compare the effects of diet support with and without the use of Continuous Glucose Monitoring (CGM) technology, which tracks blood sugar levels in real-time. The trial will take place remotely across Australia and is being conducted by a team of researchers from various Australian universities.

To participate in this trial, you need to be at least 18 years old and have a confirmed diagnosis of type 2 diabetes with a current blood sugar measurement (HbA1c) of 7% or higher. You should also have a smartphone and be able to use it independently. However, if you have certain health conditions, such as using insulin recently or having severe mental health issues, you may not be eligible. If you join the trial, you can expect to receive guidance on dietary changes and possibly use CGM technology to help monitor your blood sugar levels. This trial is still in the planning stages and hasn't started recruiting participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18+ years
• • Reside anywhere in Australia and have a postal address
• • Confirmed T2D diagnosis by a GP/endocrinologist
• • Current HbA1c of ≥7.0%
• • Have a smartphone and able to independently use it
• Exclusion Criteria:
• • Under the age of 18 years
• • Use of insulin therapy (within the last three months) or medications which interfere with blood glucose levels (i.e. steroids)
• • Use of CGM within the last six months
• • Eating Disorder Examination Questionnaire (EDE-Q) global score \>2.8 OR global score \> or equal to 1.52, with sum of Q14-18 \> or equal to 4
• • Currently having ongoing consultations with an APD or have had a consult with an APD (within last three months)
• • Not weight stable (\>5 kg change over last three months)
• • Severe hypoglycaemic event (i.e. requiring assistance) within last six months
• • Change of antihyperglcyaemic medications within last three months
• • Women who are pregnant or breastfeeding (within 24 weeks)
• • History of psychotic disorder, or current diagnosis of other major psychiatric illness (e.g. mood disorder, eating disorder, substance use disorder)
• • History of blood disorders (including but, not limited to, anemia and thalassemia) that impact the primary outcome (HbA1c)